Citation Impact
Citing Papers
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
2006
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin
2000
Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on Human Hematopoietic Progenitor Cells in Short-Term and Long-Term Bone Marrow Cultures
2000
Myofibroblasts and mechano-regulation of connective tissue remodelling
2002 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
1996
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment
2007 Standout
Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
2002
Human marrow stromal precursors are ?1 integrin subunit-positive
2000
PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
1991
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
2006 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin
2001
Acute graft-vs-host disease
2001
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Viral Chemokine Receptors and Chemokines in Human Cytomegalovirus Trafficking and Interaction with the Immune System
2002
Cytolytic pathways in haematopoietic stem-cell transplantation
2002
ACUTE BLEEDING AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: ASSOCIATION WITH GRAFT VERSUS HOST DISEASE AND EFFECT ON SURVIVAL1
1999
Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow
2004
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Graft-versus-host disease and the Th1/Th2 paradigm
1996
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
1993
Cadherin-Based Adhesion Is a Potential Target for Niche Manipulation to Protect Hematopoietic Stem Cells in Adult Bone Marrow
2010
Circulating Bone Marrow Cells Can Contribute to Neointimal Formation
2001
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Graft-versus-host disease
2009 Standout
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
1997 StandoutNature
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis
1987
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Pathophysiology of Graft-Versus-Host Disease
2006
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
Immunobiology of acute graft-versus-host disease
2003
Mechanisms of Myofibroblast Activity and Phenotypic Modulation
1999
Bone Marrow Transplantation
1994
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
2003
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Foxp3 and Natural Regulatory T Cells
2003 StandoutNobel
The Pathophysiology and Treatment of Sepsis
2003 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Atherosclerosis
2000 StandoutNature
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
1990
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Cancer of the Ovary
2004 Standout
How I treat refractory acute GVHD
2007
Proliferation and the Monoclonal Origins of Atherosclerotic Lesions
1998
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
2007 Standout
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
1991
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
1996
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Improving antibody affinity by mimicking somatic hypermutation in vitro
1999
Anti-inflammatory therapies to treat sepsis and septic shock
1997
TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J→C57BL/6J × bm12)F1 Mice
2002
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
2000
Recipient Tumor Necrosis Factor- and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
1999
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
1994
Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway
1993
T-cell depletion of HLA-identical transplants in leukemia
1991
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.
1987
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
2006
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
2001
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Cytokine dysregulation and acute graft-versus-host disease
1992
Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis
1987
Immunobiology of acute graft-versus-host disease.
1987
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.
1998
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
The tandem Src homology 2 domain of the Syk kinase: A molecular device that adapts to interphosphotyrosine distances
2003
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation
1991
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of P Hervé being referenced
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]
1990
Vascular smooth muscle differentiation of murine stroma
1999
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years
1997
Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule
2006
Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletion
1988
In situ hybridization for the detection of cytomegalovirus in blood or bone marrow leucocytes after allogeneic bone marrow transplantation
1994
Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes
1998
Treatment of Multiple Sclerosis with Anti-CD4 Monoclonal Antibody
1993
Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
1990
The cytoskeleton of stromal cells from human bone marrow cultures resembles that of cultured smooth muscle cells.
1990
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
1991
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.
1993
Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging
1990
Pilot clinical trial of an anti-TNFα monoclonal antibody for the treatment of septic shock
1995
Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells.
1997
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 cases
1986
A semi-pharmaceutical approach for the preparation of an anti-IL2 receptor monoclonal antibody in the treatment of acute GvHD in a multicentric study.
1990
Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway.
1995
Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
1991
Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement
1987
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
1991
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.
1995
Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis
1983
Autoimmune-like thrombocytopenia after bone marrow transplantation [letter; comment]
1989
Chemotherapy versus allogeneic or autologous bone marrow transplantation in second complete remission of acute lymphoblastic leukemia.
1992
Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group
1995
A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma
1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma
1985
Pilot clinical trial of an anti-TNFα monoclonal antibody for the treatment of septic shock
1995
ROLE OF MASSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKIN'S MALIGNANT LYMPHOMA
1984
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
1994